- Translation - MPIC 007/2019 February 13, 2019 Subject: Submit the Year End Financial Statement ended December 31, 2019 and clarification for the change of operating result more than 20% Attention
of the former mutual funds or the transferred mutual funds who vote to merge or amalgamate the funds and the unitholders who intend to convert the investment units of such funds into the investment
compared to the same period last year. Table 1: Sales Revenue by Product Line for the Three Months Period Ended 31 December (YoY) Product Line/ Business Group Consolidated financial statements Change
, compared to the same period of the previous year had amount of Baht 7 million, increased by amount of Baht 14 million. 3. Other incomes from gain arising from change in fair value of biological assets which
42.4% 196.5 52.0% Gross Profit 685.9 64.5% 781.9 57.6% 96.0 14.0% Other Revenues 8.6 0.8% 5.4 0.4% -3.2 -36.8% Gain from Shareholding Proportion Change in Subsidiaries to Long term investment 143.9 13.5
% in previous year to 26.43% due to change in product sales mix of general merchandise and the enhancement of directly sourced private-label goods’ profit margin, as well as the continuous efficiency
transportation costs, the gross profit margin as a percentage of sales has increased from 26.49% in the previous year to 27.10% due to change in product sales mix of general merchandise and the enhancement of
Operating Results of the Company in Q2/2020 Q2/18 Q2/19 1H/18 1H/19 Change +/(-) (THB million) YoY 1H Operating Revenue 312 144 (54%) 599 363 (39%) Gross Profit 201 79 (61%) 389 216 (44%) EBITDA 95 27 (72
building and Baht 10.0 Million from loss on change in fair value less cost to sale of biological assets, resulted from changing of fair price of fattening pigs in 2019 less than 2018. Financial Cost